Please login to the form below

Not currently logged in
Email:
Password:

Dificid

This page shows the latest Dificid news and features for those working in and with pharma, biotech and healthcare.

After delay, Merck gets US approval for serious infection drug

After delay, Merck gets US approval for serious infection drug

GlobalData says Merck will lead the market thanks to Dificid/Dificlir (fidaxomicin), which it predicts will be the biggest-selling antibiotic for these infections, while Zinplava could see competition in the

Latest news

  • EC approves first-in-class antibiotic Dificlir

    Fidaxomicin was approved in the US earlier this year where it is sold as Dificid.

  • Optimer antibiotic approved

    difficile-associated diarrhoea.". In clinical trials, Dificid worked as well as ViroPharma's Vancocin (vancomycin) in curing CDAD and was better than vancomycin at preventing recurrence of infection. ... Dificid, which is Optimer's first approved product,

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Pharma deals during December 2014 Pharma deals during December 2014

    The Optimer acquisition brought to Cubist an approved antibacterial drug for the treatment of Clostridium difficile-associated diarrhoea (CDAD) called DIFICID (fidaxomicin).  .

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    815. Optimer Pharmaceuticals / Cubist Pharmaceuticals. Acquisition. Antibiotic pipeline based on Dificid (fidaxomicin) for C.difficile (approved).

  • Pharma deals during July 2013 Pharma deals during July 2013

    Cubist had already developed a relationship with Optimer through their 2011 co-promotion agreement for Dificid (fidaxomicin), for the treatment of Clostridium difficile-associated diarrhoea (CDAD) in adults 18 years of ... Dificid was launched in the US

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...

Infographics